Clinical trial
Lycopene in Preventing Prostate Cancer in Patients Who Are at High Risk of…
NCT00416325 · University of Illinois at Chicago, Other · Completed
Key facts
| NCT number | NCT00416325 |
|---|---|
| Title | Lycopene in Preventing Prostate Cancer in Patients Who Are at High Risk of Developing Prostate Cancer |
| Official title | Phase I Multiple Dose Pharmacokinetic Study of Lycopene Delivered in a Well-Defined Food-Based Lycopene Delivery System (Tomato Paste-Oil Mixture) in Patients at Increased Risk for Developing Prostate Cancer |
| Lead sponsor | University of Illinois at Chicago, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Dietary Supplement, Other |
| Interventions | lycopene, laboratory biomarker analysis |
| Enrollment | 18 |
| Completion | Sep 1, 2006 |
| First posted | Dec 28, 2006 |
| Last update posted | Jun 26, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: